Ebola virus can be effectively neutralized by antibody produced in natural human infection

Journal of Virology

Volumn 73, Issue 7, 1999, Pages 6024-6030

  Maruyama, Toshiaki ^a   Rodriguez, Luis L ^b,d   Jahrling, Peter B ^c   Sanchez, Anthony ^b   Khan, Ali S ^b   Nichol, Stuart T ^b   Peters, C J ^b   Parren, Paul W H I ^a   Burton, Dennis R ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^d PLUM ISLAND ANIMAL DISEASE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENVELOPE PROTEIN; GLYCOPROTEIN; HUMAN MONOCLONAL ANTIBODY; IMMUNOGLOBULIN G1; NUCLEOPROTEIN;

ANIMAL CELL; ANTIBODY SPECIFICITY; ANTIBODY TITER; ANTIGEN ANTIBODY REACTION; ARTICLE; EBOLA VIRUS; IMMUNOFLUORESCENCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN SECRETION; RADIOIMMUNOPRECIPITATION; VIRUS INFECTION; VIRUS ISOLATION; VIRUS NEUTRALIZATION;

EID: 0033039502     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.7.6024-6030.1999     Document Type: Article

References (33)

1. Barbas, C. F., III, and J. Wagner. 1995. Synthetic human antibodies selecting and evolving functional protein. Methods Companion Methods Enzymol. 8:94-103.
2. Binley, J. M., H. J. Ditzel, C. F. Barbas, N. Sullivan, J. Sodroski, P. W. H. I. Parren, and D. R. Burton. 1996. Human antibody responses to HIV type 1 glycoprotein 41 cloned in phage display libraries suggest three major epitopes are recognized and give evidence for conserved antibody motifs in antigen binding. AIDS Res. Hum. Retroviruses 12:911-924.
3. Blancher, A., F. Roubinet, N. Blanchard, P. Byrne, H. Broly, J. Ducos, W. W. Socha, and J. Ruffie. 1992. Survival of human monoclonal anti-Rho (D) antibodies in the rhesus monkey. J. Med. Primatol. 21:328-331.
4. Bray, M., K. Davis, T. Geisbert, C. Schmaljohn, and J. Huggins. 1999. A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever. J. Infect. Dis. 179:S248-S258.
5. Burton, D. R., C. F. Barbas, M. A. A. Persson, S. Koenig, R. M. Chanock, and R. A. Lerner. 1991. A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals. Proc. Natl. Acad. Sci. USA 88:10134-10137.
6. Burton, D. R., J. Pyati, R. Koduri, S. J. Sharp, G. B. Thornton, P. W. H. I. Parren, L. S. W. Sawyer, R. M. Hendry, N. Dunlop, P. L. Nara, M. Lamacchla, E. Garratty, E. R. Stiehm, Y. J. Bryson, Y. Cao, J. P. Moore, D. D. Ho, and C. F. Barbas. 1994. Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody. Science 266:1024-1027.
7. Centers for Disease Control and Prevention. 1995. Outbreak of Ebola viral hemorrhagic fever - Zaire. Morbid. Mortal. Weekly Rep. 44:381-382.
8. Centers for Disease Control and Prevention. 1995. Update: outbreak of Ebola viral hemorrhagic fever - Zaire. Morbid. Mortal. Weekly Rep. 44:399.
9. Crowe, J. E., Jr., B. R. Murphy, R. M. Chanock, R. A. Williamson, C. F. Barbas, and D. R. Burton. 1994. Recombinant human RSV monoclonal antibody Fab is effective therapeutically when introduced directly into the lungs of respiratory synctial virus-infected mice. Proc. Natl. Acad. Sci. USA 91:1386-1390.
10. Gilligan, K. J., J. B. Geisbert, P. B. Jahrling, and K. Anderson. 1997. Assessment of protective immunity conferred by recombinant vaccinia viruses to guinea pigs challenged with Ebola virus. Vaccines 97:87-92.
11. Hevey, M., D. Negley, J. Geisbert, P. B. Jahrling, and A. Schmaljohn. 1997. Antigenicity and vaccine potential of Marburg virus glycoprotein expressed by baculovirus recombinants. Virology 239:206-216.
12. Jahrling, P. B., J. Geisbert, J. R. Swearengen, G. P. Jaax, T. Lewis, J. W. Huggins, J. J. Schmidt, J. W. LeDue, and C. J. Peters. 1996. Passive immunization of Ebola virus-infected cynomologus monkeys with immunoglobulin from hyperimmune horses. Arch. Virol. 11(Suppl.):135-140.
13. Jahrling, P. B., T. W. Geisbert, J. B. Geisbert, J. R. Swearengen, M. Bray, N. K. Jaax, J. W. Huggins, J. W. LeDuc, and C. J. Peters. 1999. Evaluation of immune globulin and recombinant interferon α-2b for treatment of experimental Ebola virus infections. J. Infect. Dis. 179:S224-S234.
14. Jahrling, P. B., R. A. Hesse, G. A. Eddy, K. M. Johnson, R. T. Callis, and E. L. Stephen. 1980. Lassa virus infection of rhesus monkeys: pathogenesis and treatment with ribavirin. J. Infect. Dis. 141:580-589.
15. Krasnyanskii, V. P., V. V. Mikhailov, I. V. Borisevich, V. N. Gradoboev, A. A. Evseev, and V. A. Pshenichnov. 1994. Preparation of hyperimmune horse serum to Ebola virus. Vopr. Virusol. 39:91-92. (In Russian.)
16. Kudoyarova-Zubavichene, N. M., N. N. Sergevev, A. A. Chepurnov, and S. V. Netfsov. 1999. Preparation and use of hyperimmune serum for prophylaxis and therapy of Ebola virus infections. J. Infect. Dis. 179(Suppl. 1):S218-S223.
17. Lodmell, D. L., N. B. Ray, M. J. Parnell, L. C. Ewalt, C. A. Hanlon, J. H. Shaddock, D. S. Sanderlin, and C. E. Rupprecht. 1998. DNA immunization protects nonhuman primates against rabies virus. Nat. Med. 4:949-952.
18. Marujama, T., P. W. H. I. Parren, A. Sanchez, I. Rensink, L. L. Rodriguez, A. Khan, C. J. Peters, and D. R. Burton. 1999. Recombinant human monoclonal antibodies to Ebola virus. J. Infect. Dis. 179:S235-S239.
19. Mupapa, K., M. Massamba, K. Kibadi, K. Kumula, A. Bwaka, M. Kipasa, R. Colebunders, and J. J. Muyembe-Tamfum, on behalf of the International Scientific and Technical Committee. 1999. Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. J. Infect. Dis. 179:(Suppl. 1):S18-S23.
20. Penson, M. A., R. H. Caothien, and D. R. Burton. 1991. Generation of diverse high-affinity human monoclonal antibodies by repertoire cloning. Proc. Natl. Acad. Sci. USA 88:2432-2436.
21. Peters, C. J., and J. W. LeDuc. 1999. An introduction. Ebola: the virus and the disease. J. Infect. Dis. 179(Suppl. 1):ix-xvi.
22. Peters, C. J., A. Sanchez, H. Feldmann, P. E. Rollin, S. Nichol, and T. G. Ksiazek. 1994. Filoviruses as emerging pathogens. Semin. Virol. 5:147-154.
23. Peters, C. J., A. Sanchez, P. E. Rollin, T. G. Ksiazek, and F. A. Murphy. 1996. Filoviridae: Marburg and Ebola viruses, p. 1161-1176. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology, 3rd ed. Raven Press, Inc., New York, N.Y.
24. Prince, G. A., R. L. Horswood, and R. M. Chanock. 1985. Quantitative aspects of passive immunity to respiratory syncytial virus infection in infant cotton rats. J. Virol. 55:517-520.
25. Sadek, R. F., A. S. Khan, G. Stevens, and C. J. Peters. 1999. Ebola hemorrhagic fever, Democratic Republic of Congo, 1995: determinants of survival. J. Infect. Dis. 179(Suppl. 1):S24-S27.
26. Sanchez, A., S. G. Trappier, B. W. J. Mahy, C. J. Peters, and S. T. Nichol. 1996. The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcription editing. Proc. Natl. Acad. Sci. USA 93:3602-3607.
27. Sanchez, A., Z.-Y. Yang, L. Xu, G. J. Nabel, T. Crews, and C. J. Peters. 1998. Biochemical analysis of the secreted and virion glycoproteins of Ebola virus. J. Virol. 72:6442-6447.
28. Vanderzanden, L., M. Bray, D. Fuller, T. Roberts, D. Custer, K. Spik, P. B. Jahrling, J. Huggins, A. Schmaljohn, and C. Schmaljohn. 1998. DNA vaccines expressing either the GP or NP genes of Ebola virus protect mice from lethal challenge. Virology 246:134-144.
29. Volchkov, V. E., S. Becker, V. A. Volchkova, V. A. Ternovoj, A. N. Kotov, S. V. Netesov, and H.-D. Klenk. 1995. GP mRNA of Ebola virus is edited by the Ebola virus polymerase and by T7 and vaccinia virus polymerases. Virology 214:421-430.
30. Volchkov, V. E., H. Feldmann, V. A. Volchkova, and H.-D. Klenk. 1998. Processing of the Ebola virus glycoprotein by the proprotein convertase furin. Proc. Natl. Acad. Sci. USA 95:5762-5767.
31. Volchkov, V. E., V. A. Volchkova, W. Slenczka, H.-D. Klenk, and H. Feldmann. 1998. Release of viral glycoproteins during Ebola virus infection. Virology 245:110-119.
32. Willlamson, R. A., R. Burioni, P. P. Sanaa, L. J. Partridge, C. F. Barbas, and D. R. Burton. 1993. Human monoclonal antibodies against a plethora of viral pathogens from single combinatorial libraries. Proc. Natl. Acad. Sci. USA 90:4141-4145.
33. Xu, L., A. Sanchez, Z.-Y. Yang, S. R. Zaki, E. G. Nabel, S. T. Nichol, and G. J. Nabel. 1998. Immunization for Ebola virus infection. Nat. Med. 4:37-42.